STOCK TITAN

Garden Stage (GSIW) clarifies F-3 public float limits and sales

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Garden Stage Limited filed a Form 6-K to correct cover-page disclosures in several 2025 prospectus supplements under its Form F-3 shelf. The amendments restate language tied to General Instruction I.B.5 of Form F-3, which limits public primary offerings to no more than one-third of public float when that float is below $75,000,000.

The filing specifies that, for certain prior supplements, Garden Stage sold securities worth $1,489,999.50, $2,480,000, and $6,140,000 pursuant to Instruction I.B.5. It also clarifies that the public float was approximately $112,089,026.85 as of September 15, 2025, based on 64,393,265 ordinary shares held by non-affiliates at a Nasdaq closing price of $1.73 on July 17, 2025. The updated 6-K is incorporated by reference into the company’s effective Form F-3 and its Form S-8.

Positive

  • None.

Negative

  • None.
I.B.5 12-month sales (April 9, 2025 supplement) $1,489,999.50 securities Sold during 12 months prior to April 9, 2025 pursuant to I.B.5
I.B.5 12-month sales (June 18, 2025 supplement) $2,480,000 securities Sold during 12 months prior to June 18, 2025 pursuant to I.B.5
I.B.5 12-month sales (July 25, 2025 supplement) $6,140,000 securities Sold during 12 months prior to July 25, 2025 pursuant to I.B.5
Public float $112,089,026.85 Aggregate market value of non-affiliate ordinary shares as of September 15, 2025
Non-affiliate shares 64,393,265 shares Ordinary shares held by non-affiliates used to calculate float
Share price for float calc $1.73 per share Nasdaq closing price on July 17, 2025
I.B.5 float threshold $75,000,000 Maximum public float for one-third offering cap to apply
General Instruction I.B.5. of Form F-3 regulatory
"Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby..."
public primary offering financial
"sell the securities covered hereby in a public primary offering with a value exceeding more than one-third..."
aggregate market value financial
"one-third of the aggregate market value of our Ordinary Shares in any 12-month period..."
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
public float financial
"The aggregate market value of our outstanding Ordinary Shares held by non-affiliates or public float..."
Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.
registration statement on Form F-3 regulatory
"registration statement on Form F-3 (File No. 333-283618) of Garden Stage Limited..."
A registration statement on Form F-3 is a streamlined filing used by eligible foreign companies to register securities for sale in the U.S., often as a “shelf” that lets them offer shares quickly when market conditions are right. For investors it matters because it signals that the company can raise capital on short notice—potentially increasing liquidity but also the risk of share dilution if new stock is issued—similar to a company keeping a pre-approved credit line ready to use.
registration statement on Form S-8 regulatory
"the Company’s registration statement on Form S-8 (File No. 333-287932) filed with the SEC..."
A registration statement on Form S-8 is the U.S. Securities and Exchange Commission filing companies use to register shares they intend to grant to employees, directors, consultants or benefit plans under stock compensation programs. It matters to investors because it signals potential issuance of new shares tied to pay and incentives, which can increase the total shares outstanding — like adding more slices to a pie — reducing each existing share’s ownership and potentially affecting earnings per share and stock value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does Garden Stage Limited (GSIW) report in this Form 6-K?

Garden Stage Limited files a Form 6-K to correct cover-page disclosures in several 2025 prospectus supplements. The amendments clarify limits under General Instruction I.B.5 of Form F-3 and restate amounts previously sold under that instruction.

How much has Garden Stage (GSIW) sold under Form F-3 General Instruction I.B.5?

The filing states Garden Stage sold securities worth $1,489,999.50, $2,480,000, and $6,140,000 under General Instruction I.B.5. These figures relate to specific 2025 prospectus supplements and help quantify issuance activity under the F-3 shelf.

What public float does Garden Stage (GSIW) disclose in the 6-K?

Garden Stage reports public float of approximately $112,089,026.85 as of September 15, 2025. This was calculated from 64,393,265 ordinary shares held by non-affiliates and a Nasdaq closing price of $1.73 on July 17, 2025.

How does General Instruction I.B.5 affect Garden Stage’s offerings?

Under General Instruction I.B.5 of Form F-3, Garden Stage states it will not sell securities in a public primary offering exceeding one-third of its ordinary share public float in any 12-month period while float remains under $75,000,000. This language is now clarified in the supplements.

Which registration statements incorporate this Garden Stage (GSIW) 6-K?

The Form 6-K is incorporated by reference into Garden Stage’s Form F-3 registration statement (File No. 333-283618), declared effective on March 10, 2025, and its Form S-8 registration statement (File No. 333-287932) filed on June 11, 2025.

Does this Garden Stage (GSIW) 6-K change other prospectus supplement terms?

The company states that, except for the specifically amended and restated paragraphs on the prospectus supplement cover pages, all other information in the relevant prospectus supplements remains unchanged. The 6-K focuses on clarifying cover-page disclosure language only.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For month of June 2026

 

Commission File Number: 001-41879

 

GARDEN STAGE LIMITED

(Registrant’s Name)

 

30th Floor, China Insurance Group Building

141 Des Voeux Road Central

Central, Hong Kong

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

EXPLANATORY NOTES

 

This Current Report on Form 6-K is filed for the sole purpose of correcting inadvertent errors on the cover pages of relevant prospectus supplements.

 

Paragraph 4 on the front cover page of the Prospectus Supplement dated April 9, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

 

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $1,489,999.50 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

 

Paragraph 4 on the front cover page of the Prospectus Supplement dated June 18, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

 

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $2,480,000 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

 

Paragraph 6 on the front cover page of the Prospectus Supplement dated July 25, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

 

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $6,140,000 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

 

Paragraphs 3 on the front cover page of the Prospectus Supplement dated September 17, 2025 to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph and paragraph 4 on such front cover page is hereby deleted in its entirety:

 

The aggregate market value of our outstanding Ordinary Shares held by non-affiliates or public float, as of the date of September 15, 2025, was approximately $112,089,026.85, which was calculated based on 64,393,265 Ordinary Shares held by non-affiliates and the per share price of $1.73, which was the closing price of our Ordinary Shares on Nasdaq on July 17, 2025.

 

Except as specifically amended and restated herein, all other information in the relevant prospectus supplements remain unchanged.

 

Incorporation by Reference

 

The content of this current report on Form 6-K is incorporated by reference into (i) registration statement on Form F-3 (File No. 333-283618) of Garden Stage Limited (the “Company”) that was initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 5, 2024 and declared effective by the SEC on March 10, 2025, and (ii) the Company’s registration statement on Form S-8 (File No. 333-287932) filed with the SEC on June 11, 2025, and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GARDEN STAGE LIMITED
     
Date: June 15, 2026 By: /s/ Sze Ho Chan
  Name: Sze Ho Chan
  Title: Chief Executive Officer

 

2